Phosphodiesterase type 5 inhibitors and erectile dysfunction by Catherine Whittaker

Subjects: Get full text

Ovarian cancer and the heart: pathophysiology, chemotherapy-induced cardiotoxicity, and new therapeutic strategies by Megha Nair, Arun Samidurai, Anindita Das, Sham S. Kakar, Rakesh C. Kukreja

Subjects: Get full text

Effect of long and short half-life PDE5 inhibitors on HbA1c levels: a systematic review and meta-analysisResearch in context by Joseph Kim, Rui Zhao, Lawrence Richard Kleinberg, Kitai Kim

Subjects: “…PDE5 inhibitors…”
Get full text

MANAGEMENT OF ERECTILE DYSFUNCTION IN CARDIOVASCULAR PATIENTS WITH COMORBIDITIES: REVIEW OF THE TRIALS ON CONTINUING THERAPY WITH PHOSPHODIESTERASE-5 MEDICATIONS by G. G. Sharvadze, R. R. Dalari, B. U. Mardanov, M. N. Mamedov

Subjects: Get full text

Phosphodiesterase Type 5 Inhibitors in Male Reproduction: Molecular Mechanisms and Clinical Implications for Fertility Management by Aris Kaltsas, Fotios Dimitriadis, Athanasios Zachariou, Nikolaos Sofikitis, Michael Chrisofos

Subjects: Get full text

Efficacy and safety of PDE5 inhibitors in middle-aged and old patients with and without hypogonadism by Chunlin Wang, Hui Zhang, Fu Wang, Jun Guo, Jianlin Yuan, Guangdong Hou, Ming Gao, Zheng Li, Yan Zhang

Subjects: “…Phosphodiesterase type 5 (PDE5) inhibitors…”
Get full text

Physiologically Based Pharmacokinetic Modeling for Predicting Drug Levels After Bariatric Surgery: Vardenafil Exposure Before vs. After Gastric Sleeve/Bypass by Daniel Porat, Oleg Dukhno, Sandra Cvijić, Arik Dahan

Subjects: Get full text

Erectile dysfunction as a manifestation of urogenital autonomic neuropathy in patients with type 1 diabetes: epidemiology, classification, pathophysiology, diagnosis and treatment... by Gagik Radikovich Galstyan, Yana Grigor'evna Shwarts, Sergey Anatol'evich Dubsky, Alexander Evgen'evich Lepetukhin, Roman Viktorovich Rozhivanov, Dmitry Gennadievich Kurbatov

Subjects: Get full text

Effect of Tadalafil on cardiac function and left ventricular dimensions in Duchenne muscular dystrophy: safety and cardiac MRI substudy results from a randomized, placebo-controlle... by David Cox, Barry Byrne, David W. Hammers, John Landry, H. Lee Sweeney

Subjects: Get full text

Determination of Phosphodiesterase Type 5 Enzyme (PDE-5) Inhibitors and Analogues as Adulterants in Selected Herbal Products using Gas Chromatography–Electron Impact-Mass Spectrome... by Nur Azzalia Kamaruzaman, Mazlin Mohideen, Yin-Hui Leong, Azaharudin Awang Ahmad, Norjuliana Mohd Noor

Subjects: “…Adulteration, Chromatography–electron impact-mass spectrometer (GC-EI-MS), Herbal products, Men’s sexual health, Phosphodiesterase type 5 enzyme (PDE-5) inhibitors.…”
Get full text

Therapeutic effects of mirodenafil, a phosphodiesterase 5 inhibitor, on stroke models in rats by Fred Kim, Padmanabh Singh, Hyunji Jo, Tianyang Xi, Dong-Keun Song, Sae Kwang Ku, Jai Jun Choung

Subjects: Get full text

APPLICATION OF PHOSPHODIESTERASE TYPE 5 INHIBITORS SILDENAFIL IN PATIENTS WITH PULMONARY HYPERTENSION by T. V. Martynyuk, Z. H. Dadacheva, V. M. Paramonov, O. A. Arkhipova, S. N. Nakonechnikov, I. Ye. Chazova

Subjects: Get full text

The Role of 5-Phosphodiesterase Inhibitors (PDE-5I) in Current Benign Prostatic Hyperplasia Treatment: A Narrative Review by Konstantinos Stamatiou, Gianpaolo Perletti, Vittorio Magri, Alberto Trinchieri

Subjects: Get full text